Conference catch-up: Innovation, AI & the future of pharma deal-making

Run time

11 minutes, 42 seconds

In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Strategic Account Management at Evaluate, and Carolyn Hall, Senior Director of Content and Thought Leadership Marketing at Evaluate.

After the conference, Citeline’s Managing Editor, Meredith Landry, spoke with them about their experience there and what they learned about trends in early-stage deal-making, emerging areas like cardiovascular and rare disease therapies, and the expanding role of AI in R&D.

Trajko and Carolyn also share how conferences like BIO-Europe help Norstella and its clients forge meaningful partnerships, uncover market needs, and accelerate the path to life-saving therapies through data-driven insights and strategic collaboration.

Frequently asked questions

What were the biggest themes discussed at BIO-Europe 2025?
BIO-Europe 2025 highlighted several major trends shaping the biotech and pharmaceutical industries, including increased early-stage deal-making activity, growing investment in cardiovascular and rare disease therapies, and the expanding role of AI in research and development.
How is AI influencing pharmaceutical R&D and biotech partnerships?
AI is playing an increasingly important role in helping organizations identify opportunities faster, improve decision-making, streamline research processes, and support data-driven collaboration across the drug development lifecycle.
Why are cardiovascular and rare disease therapies gaining more attention?
These therapeutic areas are attracting significant interest due to ongoing unmet patient needs, scientific advancements, and increasing opportunities for innovation, investment, and strategic partnerships.
How do conferences like BIO-Europe support life sciences organizations?
Events like BIO-Europe create opportunities for biotech and pharma companies to build strategic partnerships, identify emerging market needs, share industry insights, and accelerate the development of life-saving therapies through collaboration and data-driven discussions.
meredith-landry-headshot
Meredith Landry
Managing Editor, Citeline
trajko-spasenovski-headshot
Trajko Spasenovski
VP, Strategic Account Management, Evaluate
carolyn-hall-headshot
Carolyn Hall
Senior Director, Content and Thought Leadership Marketing, Evaluate
meredith-landry-headshot
Meredith Landry
Managing Editor, Citeline
trajko-spasenovski-headshot
Trajko Spasenovski
VP, Strategic Account Management, Evaluate
carolyn-hall-headshot
Carolyn Hall
Senior Director, Content and Thought Leadership Marketing, Evaluate

Real-world data in 2025 and beyond: Closing the strategy gap